14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Oct 22, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 21, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 20, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 19, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 18, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 15, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 14, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 13, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 12, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 11, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 08, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 07, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 06, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 05, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 04, 2021 $182.50 $182.50 $182.50 $182.50 0
Oct 01, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 30, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 29, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 28, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 27, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 24, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 23, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 22, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 21, 2021 $182.50 $182.50 $182.50 $182.50 0
Sep 20, 2021 $182.50 $182.50 $182.50 $182.50 0
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT